Enzalutamide Decreases Risk of Metastasis and Death in Men With Nonmetastatic CRPC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Enzalutamide in Men With Nonmetastatic, Castration-Resistant Prostate Cancer
N. Engl. J. Med 2018 Jun 28;378(26)2465-2474, M Hussain, K Fizazi, F Saad, P Rathenborg, N Shore, U Ferreira, P Ivashchenko, E Demirhan, K Modelska, Phung, A Krivoshik, CN SternbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.